The proliferation of the endometrium in the first half of the normal cycle is caused by the follicular hormone. The transformation into the secretion phase in the second half is caused by the hormone developed by the yellow substance of the corpus luteum. The term " menstrual " bleeding must be preserved for the discharged endometrium which has been proliferated first by the follicular hormone, and then transformed into the secretion phase (pregravid phase) by the corpus luteum hormone. The growth of the uterus in childhood and its pubescence depends on the follicular hormone (vegetative activity of the ovary), just as does the preservation of turgor in the genitals of the puberal woman. Many years ago, cyclic genital activity in the castrated animal was first produced by the injection of hormone, and this effect is now employed as a test for ovarian hormones. I succeeded eighteen months ago in producing complete menstruation in the castrated woman. The size of the doses of ovarian hormones administered is the important factor. In numerous experiments I have shown that-according to our present conceptions-very large doses of follicular hormones are required to produce the proliferation phase of the endometrium. The required dose is about 200,000 mouse units (= 1 million international units). For transformation of the proliferated endometrium into the secretion phase, 35 rabbit units of corpus luteum hormone are needed. The doses of follicular hormones up to now employed in therapeutics do not exert any traceable influence on the endometrium of the castrated woman. Neither have I noticed, that with doses of 600 or 1,000 mouse units, a shrivelling of the uterus which is due to long lasting functional troubles may be done away with. I have therefore proceeded to treat serious hormonal affections of the ovaries with very large doses of ovarian hormones. This paper reports on: (a) The effect of the follicular hormone on the hypoplastic uterus, in primary and secondary amenorrhcea; (b) spontaneous regulation of the cycle in secondary amenorrhcea also after treatment; (c) the treatment of symptoms produced by castration and at the climacteric; (d) the treatment of genital bleeding with corpus luteum hormone.
ABSTRACT.-The proliferation of the endometrium in the first half of the normal cycle is caused by the follicular hormone. The transformation into the secretion phase in the second half is caused by the hormone developed by the yellow substance of the corpus luteum. The term " menstrual " bleeding must be preserved for the discharged endometrium which has been proliferated first by the follicular hormone, and then transformed into the secretion phase (pregravid phase) by the corpus luteum hormone. The growth of the uterus in childhood and its pubescence depends on the follicular hormone (vegetative activity of the ovary), just as does the preservation of turgor in the genitals of the puberal woman. Many years ago, cyclic genital activity in the castrated animal was first produced by the injection of hormone, and this effect is now employed as a test for ovarian hormones. I succeeded eighteen months ago in producing complete menstruation in the castrated woman. The size of the doses of ovarian hormones administered is the important factor. In numerous experiments I have shown that-according to our present conceptions-very large doses of follicular hormones are required to produce the proliferation phase of the endometrium. The required dose is about 200,000 mouse units (= 1 million international units). For transformation of the proliferated endometrium into the secretion phase, 35 rabbit units of corpus luteum hormone are needed. The doses of follicular hormones up to now employed in therapeutics do not exert any traceable influence on the endometrium of the castrated woman. Neither have I noticed, that with doses of 600 or 1,000 mouse units, a shrivelling of the uterus which is due to long lasting functional troubles may be done away with. I have therefore proceeded to treat serious hormonal affections of the ovaries with very large doses of ovarian hormones. This paper reports on: (a) The effect of the follicular hormone on the hypoplastic uterus, in primary and secondary amenorrhcea; (b) spontaneous regulation of the cycle in secondary amenorrhcea also after treatment; (c) the treatment of symptoms produced by castration and at the climacteric; (d) the treatment of genital bleeding with corpus luteum hormone.
ZUSAMMENFASSUNG.-Die Proliferation der Uterus schleimhaut (Endoimietrium) in der ersten Halfte des normalen Cyklus ist Folge der Follikelhormonwirkung. Die in der 2.Halfte des Cyklus stattfindende Umwandlung in die Sekretionsphase erfolgt unter Einfluss des voni It will be seen that, even in the earliest weeks of pregnancy, the plasma, bicarbonate is considerably diminished in a high proportion of cases, namely in 80%.
In fact, an estimation of the bicarbonate may sometimes be used as a confirmatory test for the presence of pregnancy. Although it cannot compare in accuracy with recent biological methods, such as the Zondek-Ascheim test, it has the advantage of giving a rapid answer, as the estimation can be carried out in twenty minutes. Incidentally, the fact that the bicarbonate is as low in the earlier weeks of pregnancy as in the later in such a high proportion of cases would seem to disprove Shohl's hypothesis mentioned above. It should be added that no significant difference in the bicarbonate values was found in relation to age or parity.
The plasma chlorides and water content of the body.-The plasma chlorides, estimated by the method of Claudius [11] , showed a slight increase in the average value in 31 cases of normal pregnancy above that obtained in a similar number of non-pregnant women (intermenstrual values), namely, 0 599 gm. per 100 c.c.
(range 0 626 to0 572) for the pregnant; 0 585 gm. per 100 c.c. (range 0 620 to 0 541) for the Hewitt and Couper [12] have also found an increase in the whole-blood chlorides in normal pregnancy.
There is a good deal of evidence, both direct and indirect, that the water content of the blood and tissues is increased during pregnancy. Thus Zangmeister [131, in 1903 [22] also calculated an increase of 300 to 400 gm. of blood approaching term, i.e., an increase of at least 5%. The state of the capillary system was found to be normal in pregnancy, according to several observers. Further details are given in Harding's paper referred to above.
Evidence regarding the water content of the tissues is not readily obtained, but we have already brought forward indirect evidence [2], as previously mentioned, that taking various groups of normal and subnormal persons, the water content of the body as a whole, and of the subcutaneous tissues in particular, is greatest in those with the lowest plasma bicarbonate. As, apart from gross organic disease, the bicarbonate was lowest in pregnancy, of the groups studied, the tissue water content might be expected to be highest in this condition. This has been found to be the case, as is evident on purely clinical grounds, and has to some extent been confirmed by us, using the intradermal salt test of Aldrich and
McLure [23] , in which the wheal produced by the intradermal injection of 0 02 c.c. of 0 8 % saline disappears more rapidly in the cedematous than in those without this symptom. The incidence of minor degrees of waterlogging in pregnancy in fact is so universal as to suggest that it is a normal accompaniment of this state, only becoming pathological when it occurs in a degree sufficient to cause disability. The plasma bicarbonate in the toxamias of pregnancy with renal complications.
The plasma bicarbonate was estimated in 43 cases of pregnancy-toxemia with renal symptoms. These included 35 cases of pregnancy albuminuria, 4 cases of pre-eclampsia, and 4 cases of eclampsia, also 7 cases of chronic nephritis in whom pregnancy had supervened. A certain number of cases of albuminuria was Section of Therapeutics and Pharmawcology particularly the uterus, of a sexually mature woman, it is most convenient to take the normal monthly menstrual cycle as a basis. We will take as an example a woman who menstruates at regular intervals of twenty-eight days between the first day of one period and the first day of the next. What are the changes which take place in the uterus and ovaries during this time ?
In the endometrium, we differentiate between the basal and the functional layers of the mucous membrane, in accordance with the views of R. Schroder. The lowest layer of the mucous membrane, the so-called basal layer, does not take part in the monthly cyclical changes. It serves solely as a source for the regeneration of the mucous membrane after it has been destroyed during menstruation. The layer of mucous membrane which is developed from the basal layer, and which undergoes the cyclical changes which we are about to describe, is called the functional layer. In the first ten days after menstruation the mucous membrane grows considerably FIG. 1. this phase is known as the proliferation phase. This growth and modification of the endometrium is due to the influence of the ripening graafian follicle. In the second half of the cycle the proliferated mucous membrane is converted into the secretory phase. This latter change is brought abput by the influence of the corpus luteum, which is developed from the ripe follicle. When the corpus luteum retrogresses, menstruation commences. At the time of menstruation the mucous membrane which is in the secretory phase is thrown off together with haemorrhage.
The details of the changes in the endometrium are shown in the accompanying llustrations of three microscopical sections. Figure 1 shows the narrow layer of mucous membrane, shortly after menstruation. Here only basal mucous membrane is present.
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Proceedings of the Royal Society of Medicine Figure 2 shows the increase in breadth of the mucous membrane at the end of the first tentdays of the cycle.
This stage of development-the proliferation phase-is coincident with the growth of the graafian follicle in the ovary. To-day we know with certainty that the follicle produces this endometrial growth by means of the cestrin which it elaborates.
In the second half of the cycle the follicle, after the escape of the ovum, is converted into a yellow body or corpus luteum, which produces a second hormone, totally different from cestrin biologically, but closely related to it chemically. The corpus luteum hormone transforms the proliferated mucous membrane into the secretory phase.
This change is shown in figure 3 . The marked convolution of the glands is a feature of the secretory phase.
The whole purpose of these changes is to produce ideal conditions for the nidation of a fertilized ovum. If the ovum does not become fertilized, this endometrial development is no longer of any value. The corpus luteum retrogresses unless the presence of the fertilized ovum stimulates it to persist. The retrogression of the corpus luteum, and the consequent withdrawal of its hormone, lead to menstrual bleeding, that is to say, the highly developed mucous membrane is destroyed by hamorrhage and is rejected together with the extravasated blood. It is most important 114 852 s4 Section of Therapeutics and Pharmacology 853 to impress this clearly defined conception of menstrual bleeding upon our minds. In true menstrual bleeding in a healthy woman, the endometrium which has been brought to the proliferation stage by the action of cestrin, and subsequently transformed into the secretory phase under the influence of the corpus luteum hormone, is rejected, accompanied by haemorrhage, as a result of the cessation of the action of the corpus luteum hormone. This important point has been constantly emphasized in England, by Shaw. Particles of the discarded mucous membrane can be histologically demonstrated in the menstrual discharge. Thus, when attempting to reproduce menstruation experimentally by the administration of hormones, only those heemorrhages should be regarded as true menstrual bleeding in which morsels of mucous membrane, showing the changes typical of the secretory phase, can be demonstrated histologically. In the life of the sexually mature woman this train of events is repeated at regular intervals from the beginning of the first menstrual period until the onset of the menopause, unless it be temporarily suspended by the nidation of a fertilized ovum and the resulting pregnancy.
Even before the occurrence of the first menstrual period, during so-called puberty, the ovary exercises a hormonal function, in that numerous immature follicles secrete cestrin. The effect of this activity is to produce the proper growth of the uterus and to control the turgidity of the entire genital apparatus, including the vagina. The whole follicular apparatus continues to produce cestrin even in the sexually mature woman and tbereby maintains the uterus in the normal condition of turgidity. We shall see later that individuals exist in whom this so-called vegetative function of the follicles is deficient. In these women, as a result of the lack of cestrin, the whole genital apparatus remains in the condition typical for the young girl before the onset of puberty. It must be remembered that this vegetative function of the follicular apparatus comes into play years before the appearance of the first menstrual period and still continues after the commencement of the menses. With this fact before our minds, it will be at once obvious how difficult and prolonged treatment must be in women in whom this function of the ovaries is deficient.
The knowledge that the above described changes in the ovaries and uterus take place during the monthly cycle, in the sequence shown in our figures, was obtained in anatomical experiments. These are associated with the names of Hitschmann and Adler, Robert Meyer and Robert Schroder. Animal experiments have proved that oestrin produces the proliferation of the endometrium, and that the secretory phase is brought about by the subsequent action of the corpus luteum hormone. The brilliant results obtained in experiments on castrated monkeys showed that these cyclical changes in the uterus could be accurateiy imitated by the administration of the two hormones. With this knowledge it was natural that many observers attempted to reproduce the menstrual cycle in castrated women by the same means. Nevertheless, these attempts were unsuccessful. Various authors described changes in the endometrium resulting from the administration of hormones to castrated women, but none of the descriptions will bear close criticism.
After many vain attempts I constantly occupied myself with the following question: Why is it that we can reproduce the sexual cycle so accurately in animals, whereas in women we have no success? My astonishment at this discrepancy was still further increased by the fact that the American workers, Smith and Engle, were able to produce the complete cycle in a castrated monkey with a menstrual cycle very similar to that of the normal woman.
Two years ago I again took up this question. At this time it was considered useless to administer more than 600 mouse units daily. This contention was based on estimations of the amount of hormone in the urine. In my experience these doses produced no effect whatever on the endometrium of castrated women. At this stage the results of the important and fundamental experiments of Parkes and Zuckermann on the dosage required in female baboons were available. On the basis of these experiments, which unfortunately did not receive sufficient attention from clinicians, Parkes and Zuckermann maintained that the dosage necessary in women must be very much larger than that so far employed.' On January 15, 1932, speaking at a meeting of the Section of Obstetrics and Gynecology of this Society, Parkes prophesied with remarkable foresight that the dosage necessary in women would be in the neighbourhood of 500,000 mouse units. I was fortunate enough at this time to witness the experiments of Schoeller, Dohrn and Hohlweg, on the dose necessary for the female baboon, which they were then carrying out in order to confirm Parkes's work. Impressed by these, I immediately decided to work with much higher doses.
Even with much higher doses the results were at first unsatisfactory. Only when I employed a dose of 1,000,000 international units of cestrin-a truly colossal figure in comparison to our previous estimates-was I successful. With this amount I was able to produce changes in the endometrium of a castrated patient in every way comparable to the normal physiological condition in the healthy woman. We see, therefore, that the whole problem is a question of dosage.
In the following figures you will see the results of my first experiments.
My patient was a 21-year-old girl who had been castrated five years previously on account of dermoid cysts in both ovaries. Before the commencement of hormone therapy the uterus was in an atrophic condition, only isolated simple tubular glands being present in the shrunken stroma. Figure 4 shows the condiuion of the endometrium of the same patient after the administration of 1,000,000 international units of oestrin and 35 rabbit units of corpus luteum hormone. The mucous membrane has grown enormously and is in the secretory phase. Its condition corresponds exactly with that found in the normally, menstruating woman a day or so before the commencement of the period.
In this first experiment I did not wait for the occurrence of menstrual bleeding but removed the portion of endometrium which you have just seen as soon as the hormone administration was complete. I felt convinced that this highly developed mucous membrane would be subsequently discarded, accompanied by haemorrhage.
However, in order to be absolutely certain, I repeated the experiment and this time I waited for the onset of menstruation. Bleeding commenced two days after the FIG. 4. last injection of corpus luteum hormone. In the discharge were particles of mucous membrane, which histologically presented the appearance shown in the next figure. Figure 5 (p. 48) shows a section of endometrium with markedly convoluted, actively secreting glands. Abundance of glycogen was demonstrated in the glandular epithelium and showed that the glands are in a condition of marked functional activity. According to the investigations of Ascbheim, Driesen and Wegelin, this histological picture is characteristic of an actively functioning endometrium.
I was thus able for the first time to reproduce exactly the normal cycle in a castrated woman. At the same time this experiment showed that the two ovarian hormones, cestrin and corpus luteum hormone, are the only hormones required to produce the full functional development of the endometrium.
As the dosage question seemed to me to be of the greatest importance, I dedicated 47 855 my next experiments to the solution of this problem. There is no point in recapitulating the details of these experiments here. Suffice it to say that in order to bring about the normal degree of proliferation, the most suitable dose was found to be 1,000,000 international units of cestrin. Growth of the mucous membrane can be obtained with smaller doses but these do not produce the same degree of development as is found in the healthy woman at the end of the proliferation phase. I particularly wish to emphasize this point because other observers have frequently maintained that the proliferation phase may be produced with smaller doses. When photographs of mucous membrane are published as proof of the hormonal action on the endometrium, we can with justice demand that a positive hormone effect can only be claimed when the mucous membrane shows a certain degree of resemblance to the condition of the endometrium wvhich we know to be typical of the normal cycle. Unfortunately several papers which have recently been published do not appear to me to satisfy this demand.
FIG. 5.
To repeat: My experiments showed that to reproduce the proliferation phase in the endometrium of a castrated woman on a single occasion, 1,000,000 international units of cestrin are necessary. Castration necessarily involves the complete abeyance of endogenous hormone production. I carried out my experiments on castrated women because only in this way can we come to a clear-cut decision as to the dosage required for the complete development of the endometrium.
The results above described led me to the conclusion that in the treatment of women who, though not castrated, are suffering from severe ovarian disturbances, the low doses of hormone previouslv employed must be useless.
Before we turn to the results of treatment in sick women we must first answer the following question, " What happens if we administer too much cestrin ?" Experiments to this end were also carried out on castrated women. We gynmcologists frequently encounter the well-known clinical syndrome of cystic hyperplasia of the endometrium accompanied by totally irregular and often very severe haomorrhage. Even before the era of hormones, anatomical investigations had enabled us to form a correct conception of the evolution of this malady.
In glandular cystic hyperplasia the normal cycle of development, of which regular menstruation is the outward sign, is completely disturbed. At the end of the normal proliferation phase, that is, some fourteen days after the previous period, the mucous membrane continues to grow and becomes much higher than in the normal condition. In addition, the glands are cystic and dilated. After some time haemorrhage, which is frequently of a severe nature, takes place from this overproliferated mucous membrane.
The question immediately arises: " What endocrine process underlies this condition of the endometrium? " You will remember that in the middle of the normal menstrual cycle the mature graafian follicle bursts and that after the expulsion of the ovum it is transformed into a corpus luteum. FIG. 6. In cystic hyperplasia the follicle does not rupture and no corpus luteum is formed. The enlarged persistent follicle continues to produce nstrin and excessive proliferation of a pathological nature is the result. In this way cystic hyperplasia of the endometrium is brought about.
If the above explanation is correct it should be possible to produce true cystic hyperplasia of the endometrium in a castrated woman by administering excessive doses of cestrin. I also succeeded in this attempt, although very large doses were necessary; I was obliged to administer over 5,000,000 international units of aestrin, spread over several weeks, in order to obtain the true picture of cystic hyperplasia.
The result of the experiment is seen in the above illustration, fig. 6 , which shows numerous dilated cystic glands. None of these glands, however, is convoluted and none contains glycogen. The characteristic Isigns of the corpus luteum hormone 858 Proceedings of the Royal Society of Medicine 50 function are therefore absent. The result of this experiment explains the aetiology of this common gynaecological disordei. We see, therefore, that too small a dose produces insufficient proliferation, whereas too large a dose produces cystic hyperplasia of the endometrium.
It is unfortunate that we have to express ourselves in such enormous figures and I would like to make a few observations on this point. I myself was at first greatly perturbed at the thought of having to work with hundreds of thousands of mouse units. For several years we had been under the erroneous impression that it was possible to produce proliferation of the endometrium in a woman with a few hundred rat or mouse units. We now know that this is impossible and we also know the dose necessary in a castrsated woman in order to produce full endometrial development. It seems to me desirable that, for the future, we no longer refer to this amount as a high dosage of hormone, but as the physiological dosage. This is all the more reasonable in view of the fact that 50,000 international units correspond to 1 mgm. of di-hydro-cestrin. Thus to produce physiological proliferation we must administer a daily dose of 1 mgm. This effectively disposes of the high figures.
I have discussed this point at length for a definite reason. From the very first I occupied myself with the question as to whether the doses of hormone which I employed were capable of producing any damage. It was found that this was only the case when a gross overdose was administered, as for example in my experimental production of cystic hyperplasia of the endometrium. It may be shown, for example, that harmful effects are produced by administering several hundred mouse units to a mouse. In my opinion it is misleading to draw conclusions relative to human therapy from such observations, since if we are to produce similar pathological effects in human beings, doses of many millions of international units must be used. I mention this point because it is important not to permit erroneous conclusions derived from inadmissible animal experiments to confuse our therapeutic researches.
We may now turn to my therapeutic experiments. All of these were carried out in the Gynecological Clinic of the Charite in Berlin. My teacher Professor Wagner has given me much help and encouragement throughout these investigations.
The results of the above described experiments pointed the way for my next investigations.
I was now convinced that in amenorrhcea of long standing, and in cases with arrested development of the uterus, small doses of oestrin were useless. I would emphasize here that I rejected all cases with amenorrheea of short duration, since these do not provide a reliable criterion of the success of treatment. For obvious reasons also, only those cases were selected in wbich the amenorrhbea was primarily due to deficiency of ovarian hormone.
Before carrying out hormone therapy the patient must be thoroughly examined, in order to exclude the possibility of the endocrine disturbance being secondary to some other disease. Such disturbances are particularly common, for instance, in incipient pulmonary tuberculosis.
Therapeutic experiments on a large scale with high doses of cestrin first became practicable when the technique of injection was simplified by the introduction of highly concentrated preparations. In my first experiments I employed daily injections of cestrin benzoate, 1 c.c. of which contained 50,000 international units. All my later work was carried out with twice-weekly injections of cestrin, 1 c.c. of which contained 250,000 international units. We owe this highly concentrated preparation to the researches of the chemists, Schwenk and Hildebrandt, who showed that hydrogenation converts cestrin into a much more a,ctive derivative.
Let us first consider the case of women with primary amenorrhcea accompanied by marked hypoplasia of the genitalia. In most of them the uterus is scarcely larger than a hazel-nut and until recently all forms of therapy have been unsuccessful in these cases. Here the immediate aim of treatment is not to produce menstruation Section qf Therapeutics and Pharmacology but to stimulate the infantile uterus to grow. The development of the uterus is dependent upon the presence of the follicular hormone and for this reason I gave such women 500,000 international units of cestrin weekly over a period of months. During the course of treatment no damage or disturbances of any kind was observed. From the first it was obvious that treatment would have to be prolonged, since in these women we have to make up for a hormone deficiency which has persisted throughout puberty, at a time when the uterus of the normal young girl is steadily developing under the constant influence of oestrin.
I have records of five women in whom the uterus, before treatment, was not larger than a hazel-nut. In three of these an astounding degree of growth was obtained as a result of follicular hormone therapy. The length of treatment and the total dosage naturally differed from case to case. In one patient a marked enlargemient of the uterus was demonstrable after the administration of 3,000,000 international units.
Another patient's progress was particularly interesting. She was a 19-year-old hospital nurse, fully developed, but with primary amenorrhcea. The body of the uterus was not larger than the tip of the little finger. She came under my care last July. In the first three months she received in all 4,250,000 international units of cestrin. During this period the uterus became softer and more turgid but there was no increase in size. I advised the patient to continue and in the next three months a further 4,500,000 units were administered, so that in the first six months a total dose of 8,750,000 units were injected. In spite of this the uterus still seemed to me to be no larger. For this reason, during the following weeks, I injected 1,000,000 international units weekly. In a short time, the uterus had so greatly increased in size, that, without knowing the patient's history, it would have been impossible to distinguish it from the uterus of a normally menstruating woman. In two of my five cases I had no success. In one of these I was unable to continue treatment for more than six months, and the other showed no improvement after receiving 15,000,000 international units in the space of seven months.
It is worthy of note that in these cases of primary amenorrhcea, only slight haemorrhages of short duration occurred during this treatment. They must be regarded as due to the influence of cestrin alone, and not as true menstruation. Only on one occasion did a more extensive haemorrhage occur and in this case histological examination of fragments of mucosa from the discharge showed the typical picture of cystic hyperplasia of the endometrium. After a pause of fourteen days I continued to administer cestrin to this patient and no further marked haemorrhages were observed.
From the first three cases in this group it will be seen that with sufficient doses of cestrin, even extremely hypoplastic uteri can be brought to an advanced stage of development. We shall have gained very little, however, if the effect of follicular hormone stops here. I think, however, that we are at least justified in hoping that by means of cestrin we may be able to stimulate the whole endocrine system. After all, the only real therapeutic advance will have been made when we are able to produce spontaneous normal menstrual periods in these cases of primary amenorrhcea. Nevertheless, those of you who have experienced the complete failure of every other method of treatment in this condition will understand our satisfaction with our results. It is interesting to note that in our cases, the psychic depression which is so common in these patients, was much relieved by the treatment.
Whereas in patients with undeveloped genitalia a sufficient criterion of the success of treatment is provided by the increase in size of the uterus, in secondary amenorrhcea our only tangible guide is the production of true menstruation. From my experiments on castrated women we may assume that with sufficient doses of cestrin and corpus luteum hormone this must be possible.
I treated my cases of secondary amenorrhaea in several different ways. In one 51 859 group I imitated the course of events occurring during the normal menstrual cycle just as I had done in castrated women. These patients, therefore, first received aestrin and afterwards corpus luteum hormone, as is shown in the following scheme ( fig. 7) .
At first 250,000 international units of cestrin were injected every three days on five occasions. After a pause of three days 35 rabbit units of corpus luteum hormone were given over a period of five consecutive days. On the second day after the last corpus luteum hormone injection menstrual bleeding commenced.
With few exceptions, I succeeded in producing true menstrual bleeding every time in 40 patients. That the haemorrhage was true menstrual bleeding was proved by histological examination. Indeed, this exact method of investigation is the only reliable method of distinguishing between true menstruation and the so-called " interval bleeding " which takes place from an endometrium in the proliferation phase.
Since, as I stated above, the cases treated were all of an advanced type and of long-standing, I thought it advisable to produce menstruation artificially for three consecutive months. We come now to the important point: What happens when treatment is discontinued ? At the present time I can only answer this question in terms of my limited experience and with all due reservation. Completely regular spontaneous menstruation may take place for several months, but in cases of severe disturbance of ovarian function I found that one must be prepared for the reappearance of amenorrhcea after a few months.
Of particular interest was a second group of cases which I treated with cestrin alone, without the aid of corpus luteum hormone.
With doses of 1,000,000 international units, hamorrhages were observed which were partly "interval hwmorrhages "-that is, bleeding from an endometrium in the proliferation phase-and partly true menstruation-that is, bleeding from an endometrium in the secretory phase. In the latter case one must assume that the ovaries of the patient concerned were able to produce sufficient corpus luteum hormone to complete the work of the artificially supplied aestrin and to convert the endometrium from the proliferation phase to the secretory phase. 52 860 37 Section of Ophthalmology 893
Recovery of sight was accompanied by relief of pain, and this woman who for a year past had been unable to work-except for an unsuccessful two months' struggle in the middle-by reason of severe daily headache, and vision often too dim to distinguish objects clearly, has now been back at her work as a parlourmaid for eight months with practically no disability.
There are two points in this case which seem to me important. First, that behind the obvious choroiditis lay hidden an unsuspected and more dangerous retrobulbar neuritis. I am afraid that in the past the presence of a fundus lesion has usually seemed to me sufficient cause for blindness. This case suggests to me that in future it will be unsafe to attribute blindness to any fundus lesion unless a scotometer record has excluded the possibility of an accompanying nerve lesion.
But if my diagnosis is correct, it is the presence of an unsuspected sinusitis that is of primary importance in this case.
I do not know if I have offered sufficient proof to establish my contention that Proceedings of the Royal Society of Medicine 54 to have in many lower mammals, yet it was clearly the causative factor in the proliferation of the endometrium during the time of follicular growth, and was, moreover, essential for the subsequent action of progestin. The dosage of both oestrin and progestin found necessary by Dr. Kaufmann was actually rather more than would have been expected on a body-weight basis when compared with the amount required for the mouse, rat, and baboon. One million International Units represented 0 i 1 grm. of pure ketohydroxycestrin, which was about twice as potent (assayed on mice) as trihydroxycestrin; 0' 2 grm. of the latter would therefore be required. This substance had a maximum solubility in oil of about 5 mgm. per c.c., so that 40 c.c. concentrated oil solution of trihydroxycestrin would be required to give the necessary dose. This was obviously an inconveniently large amount of oil to give over a short period. For this reason ketohydroxycestrin should be used where possible. Professor E. C. DODDS: I, also, am fortunate in having confirmed in detail the results that Dr. Kaufmann has described in his most interesting and brilliant paper.
Dr. Kaufmann very kindly supplied me with particulars of his technique before it was published, so that similar experiments could be conducted over here. Using the same material, we were able to show that menstruation could be produced with the quantities of cestrin and progestin described by Dr. Kaufmann. As in his experiments, our results were checked by curettage and subsequent histological examination.
There is perhaps one point that may not be quite clear to some of the audience this evening, namely, the actual material that was used as the cestrogenic substance. Dr. Parkes has just informed us that the Medical Research Council trials were undertaken with trihydroxycestrin, and that this substance is considerably less potent than ketohydroxycestrin, but that it was used for their tests owing to its availability. Dr. Parkes has also pointed out the relatively enormous quantity of trihydroxycestrin that would be required to produce the same unitage as is demanded by Dr. Kaufmann for his technique.
The material that Dr. Kaufmann used, however, was not the naturally occurring hormone, but was a derivative of ketohydroxycestrin. It has been shown by Butenandt that trihydroxycestrin may be converted to ketohydroxycestrin by distillation in vacuum over potassium bisulphate, and that this materially increased the number of units. Now if the ketohydroxy cestrin molecule be hydrogenated, then the dihydro compound is first formed, and this has four times the potency of ketohydroxycestrin. Consequently, one quarter the weight only need be given to produce the same effect as ketohydroxycestrin. By this means Dr. Kaufmann was able to give the enormous doses that he has described in convenient quantities for subcutaneous injection. The relationship between the three compounds is shown graphically as follows: Dr. H. GARDINER HILL: I should like to take this opportunity of thanking Dr. Kaufmann and Messrs. Schering for providing me, during the last nine months, with supplies of his concentrated cestrin and corpus luteum extracts. The preparations have been of the same concentration as that which he himself uses-cestrin, 50,000 mouse units per dose, proluton 10 rabbit units per dose. The method of administration has been as directed by Dr. Kaufmann, that is, doses of cestrin have been given on the 1st, 4th, 8th, 11th and 15th of the month, whilst the proluton has been given subsequently on five consecutive days, the 19th, 20th, 21st, 22nd and 23rd. The injections have been made intramuscularly, and only in one case has, there been any local reaction. I will now give briefly the results of my experience with these extracts, and I think it will be agreed that they confirm, as far as they go, Dr. Kaufmann's own observations. I can give details of six cases, in which the extracts have been given a trial. The first two were straightforward cases of secondary amenorrhoea in otherwise normal married women ,aged 25 and 33 respectively. The secondary amenorrhoea had been of two years' and seven years 55 Section of Therapeutics and Pharmacology 863 duration respectively. Both were sterile. Both had been examined by a gynecologist, and no pelvic abnormality was found, except that in the second case there was a slightly atrophied condition of the cervix and uterus. Both were normal from the point of view of secondary sex characters. In the first, menstruation (since puberty at the age of 15) had been quite regular, up to the onset of the amenorrhcea. In the second, menstruation began at the age of 11, was somewhat irregular until marriage, and subsequently normal until the period of amenorrhoea started. In the first case amenorrhcea dated from a shock, in the second case it followed a miscarriage. Both had received numerous courses of treatment with various ovarian extracts, but in neither had any effect been observed.
The first patient (secondary amenorrhcea two years) began her first course of oestrinproluton in May 1933. The last injection of proluton was given on May 25. Forty-eight hours later, a hEemorrhage occurred and lasted four days. This, according to the patient, seemed to be in every way like a normal period. No further treatment was given until August. In June and July no period came on. On August 2 the second course was begun, finishing on August 24. Heimorrhage occurred on August 26, i.e. two days after the last injection-and lasted four days. No further treatment was given until November, and the periods in September and October were missed. The third course in November resulted in another loss for four days, two days after the last injection of proluton.
In the case of the second patient (secondary amenorrhcea, seven years), the first course was begun in July and finished on July 27. A hemorrhage occurred fifty-six hours after the last injection of proluton, and lasted four days. No further treatment was given until November, and no periods occurred in the interval. The final injection of proluton in the second course was given on December 24 and a hEemorrhage occurred twenty-six hours later. In this case the losses lasted again for four days and the patient herself considered that they corresponded in every way to those of a normal period. I heard from her a day or two ago to the effect that no period had come on in January. The next two cases were of a slightly different type, in women aged 24 and 23 respectively, with secondary amenorrhcea of six years' and fourteen months' duration respectively. In the first case puberty had occurred at the age of 15, and menstruation had always been regular until the period of amenorrhcea began. In the second case puberty began at the age of 12, and menstruation had always been regular until the period of amenorrhoea. Both these individuals were quite normally developed from the point of view of secondary sex characteristics. Clinically, they should, I think, be regarded as typical cases of anorexia nervosa. In both instances, the onset of the period of amenorrhcea coincided with a nervous breakdown. In both the chief symptom was a very striking loss of appetite, with loss of weight. The first patient lost 3 st. and the second lost 38 st. in weight. This particular type of amenorrhoea is generally the most resistant to any form of ovarian therapy. The first patient was *treated with cestrin-proluton in December, and the last injection of proluton was given on January 10. A hiemorrhage occurred forty hours later, and lasted for five days. Sufficient time has not elapsed for me to be able to give any information about the subsequent period.
In the second case, the last injection of proluton was given on January 30, and a hLemorrhage occurred forty-eight hours later. Sufficient time has not elapsed in the case of this patient also to furnish information about any subsequent period.
The remaining two cases are of a very different type, both examples of primary amenorrheea in infantile individuals. The first patient, aged 19, had never menstruated, and there was no development of the secondary sex characters. The general condition rather suggested a mild grade of eunuchoidism. There was no evidence of any pituitary lesion. Two courses of cestrin-proluton were given, but without any effect. The second case in this group was also an instance of primary amenorrhcea and infantilism. The clinical condition of this patient suggested an anterior lobe pituitary deficiency. The girl was short and somewhat disproportioned, and there were no secondary sex characters. This individual was given a course of cestrin-proluton without any effect either on menstruation or the secondary sex characters.
To sum up, therefore, my experiencies with Professor Kaufmann's extracts, it would seem that in secondary amenorrhoea, even the most resistant cases respond to this treatment, that is, a hemorrhage has resulted, usually within two days of the last injection of proluton, in every case treated. On the other hand, there is no instance in this series of a subsequent haemorrhage oceurri-ng. spontaneously. In neither of the married women was there any beneficial effect with regard to sterility. In the two cases of primary amenorrhcea and infantilism treated, there has been no striking change.
